• Istituto di Biologia e Patologia Molecolari


Tel :+390649912827
Fax :+390649912343
roberto.piergentili@cnr.it
ROBERTO PIERGENTILI
Researcher

Istitute of Molecular Biology and Pathology - National Research Council
Department of Biology and Biotecnology - Charles Darwin
Sapienza University of Rome - Istituto Genetica, room 1-07 - P.Le A.Moro 5 00185 Roma
RESEARCH INTERESTS
My research interests cover many aspects of chromatin structure and function. I study this topic by selecting mutations in Drosophila melanogaster and analyzing how they affect chromosome behavior and, consequently, mitotic and male meiotic divisions. In particular, I focus on the cytological effects of these mutations on cytokinesis.
 
I am also interested in the analysis of chromosome structure, with particular emphasis on the molecular mechanisms of telomeric fusions and the genetic and molecular characterization of mutations causing chromosome breakage.
 
I also have an ongoing analysis of Y chromosome-associated heterochromatin with a specific interest on alternative DNA structures.

Finally, collaborations exist with physicians of the San Camillo Hospital (Roma) for the study of the human urogenital tract, its diseases and its development.
SELECTED PUBLICATIONS

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

 
PUBLICATIONS (last ten years, selected – starting from newest):

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415
SELECTED PUBLICATIONS

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

 
PUBLICATIONS (last ten years, selected – starting from newest):

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415
SELECTED PUBLICATIONS

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

 
PUBLICATIONS (last ten years, selected – starting from newest):

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415
SELECTED PUBLICATIONS

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

 
PUBLICATIONS (last ten years, selected – starting from newest):

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415
SELECTED PUBLICATIONS

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

 
PUBLICATIONS (last ten years, selected – starting from newest):

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415

PUBLICATIONS (last ten years, selected – starting from newest):

 

  • Piergentili R, Del Rio A, Signore F, Umani Ronchi F, Marinelli E, Zaami S. CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells. 2021 Apr 21;10(5):969.
  • Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci. 2021 Mar 19;22(6):3151.
  • Zaami S, Piergentili R, Marinelli E, Montanari Vergallo G. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1752-1761.
  • Gulìa C, Signore F, Gaffi M, Gigli S, Votino R, Nucciotti R, Bertacca L, Zaami S, Baffa A, Santini E, Porrello A, Piergentili R. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers (Basel). 2020 May 14;12(5):1238.
  • Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020 Jan 31;21(3):933.
  • Signore F, Gulìa C, Votino R, De Leo V, Zaami S, Putignani L, Gigli S, Santini E, Bertacca L, Porrello A, Piergentili R. The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility. Genes (Basel). 2019 Dec 29;11(1):40.
  • Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, Signore F, Vallone C, Nucciotti R, Costantini FM, Pizzuti A, Bernardo S, Porrello A, Piergentili R. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887.
  • Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, Signore F. Non-Coding RNAs and Endometrial Cancer. Genes (Basel). 2018 Mar 29;9(4).
  • Capozza N, Gulia C, Heidari Bateni Z, Zangari A, Gigli S, Briganti V, Tursini S, Koh CJ, Gaffi M, Baldassarra S, Signore F, Porrello A, Piergentili R. Vesicoureteral reflux in infants: what do we know about the gender prevalence by age? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5321-5329.
  • Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R.
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes (Basel). 2017 Nov 22;8(11).
  • Frappaolo A, Sechi S, Kumagai T, Robinson S, Fraschini R, Karimpour-Ghahnavieh A, Belloni G, Piergentili R, Tiemeyer KH, Tiemeyer M, Giansanti MG. COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes. J Cell Sci. 2017 Nov 1;130(21):3637-3649.
  • Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med. 2018 May;31(9):1234-1240.
  • Gulia C, Zangari A, Briganti V, Bateni ZH, Porrello A, Piergentili R. Labia minora hypertrophy: causes, impact on women's health, and treatment options. Int Urogynecol J. 2017 Oct;28(10):1453-1461.
  • A. Frappaolo, S. Sechi, G. Belloni, R. Piergentili, MG. Giansanti. Visualization of cleavage furrow proteins in fixed dividing spermatocytes. Methods Cell Biol. 2017;137:85-103.
  • A. Porrello and R. Piergentili. Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets. Current Genomics, 2016; 17(1):33-61
  • R. Piergentili. Editorial - Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics. Current Genomics, 2016; 17(1):2-3
  • Marrocco G, Grammatico P, Vallasciani S, Gulia C, Zangari A, Marrocco F, Bateni ZH, Porrello A, Piergentili R. Environmental, parental and gestational factors that influence the occurrence of hypospadias in male patients. J Pediatr Urol. 2015;11(1):12-19
  • Piergentili R. Rediscovery and characterization of mus309[D1]. Dros Inf Serv, 2014; 97:173-175
  • S. Vallasciani, G. Marrocco, C. Gulia, A. Zangari, R. Piergentili. Bladder Cancer in Pediatric Patients. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 45-69. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • C. Gulia, G. Marrocco, S. Vallasciani, R. Piergentili. The Five Senses in Bladder Cancer Diagnostics. In: 'Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges', 2014, pp. 17-43. New York: NovaScience Publishers inc. ISBN:978-1-63321-666-2
  • Piergentili R, Carradori S, Gulia C, DeMonte C, CristiniC, Grande P, Santini E, Gentile V, Di Pierro GB. Bladder cancer: innovative approaches beyond the diagnosis. Curr Med Chem. 2014; 21:2219-2236. 
  • V. Mengoli, E. Bucciarelli, R. Lattao, R. Piergentili, M. Gatti, S. Bonaccorsi. The analysis of mutant alleles of different strength reveals multiple functions of Topoisomerase 2 in regulation of Drosophila chromosome structure.  PLoS Genetics 2014; 10:e1004739
  • Piergentili R. (2013) How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2:28-40
  • Piergentili R. (2013) Zooming (a little) out of the M-theory. J Mol Biochem 2:3-5
  • Giansanti M.G., Sechi S., Frappaolo A., Belloni G. and Piergentili R. (2012) Cytokinesis in Drosophila male meiosis. Spermatogenesis 2:185-196
  • Di Pierro G.B., Gulia C., Cristini C., Fraietta G., Marini L., Grande P., Gentile V. and Piergentili R. (2012) Bladder cancer: a simple model becomes complex. Curr Genomics 13:395-415
COLLABORATIONS
Collaborations within IBPM:
Dr MG Giansanti
Dr F di Rosa
 
 
Collaborations with other Institutions:
Dr A Porrello, Comprehensive Cancer Center (LCCC), University of North Carolina (UNC)-Chapel Hill, USA.
Dr V Briganti, Dr C Gulìa and Dr F Signore, Azienda Ospedaliera San Camillo Forlanini, Roma.
CV
TEACHING ACTIVITY:
 
2016-2017 - Adjunct Professor of Genetics at Sapienza - Università di Roma
2003-2012 - Adjunct Professor of Genetics at Università di Urbino "Carlo Bo".
2009-2010 - Adjunct Professor of Genetics at Sapienza - Università di Roma - Polo di Latina (Università Pontina).
 
SCIENTIFIC ACTIVITY:
 
2012-present: Researcher at CNR-IBPM
2010-2012: Research Fellow at Sapienza - Università di Roma
2008: international fellowship at Umea University (Sweden, Prof. A. Chabes' Lab)
2005-2007: Research Fellow at Sapienza - Università di Roma
2002 and 2011: training course in Bioinformatics
2002: training course in Mass Spectrometry
1999-2000: international fellowship at UC Davis (CA-USA, Prof. K. C. Burtis' Lab)
1999: PhD degree in Genetics and Molecular Biology
1993: graduation in Biology

CERTIFICATIONS:

2018: Project Manager certified by ACCREDIA
2017: Project Management Advanced (ISIPM)
2016: Project Management Basic (ISIPM)